These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22886255)

  • 1. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.
    Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J
    Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains.
    Hussack G; Ryan S; van Faassen H; Rossotti M; MacKenzie CR; Tanha J
    PLoS One; 2018; 13(12):e0208978. PubMed ID: 30540857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.
    Andersen KK; Strokappe NM; Hultberg A; Truusalu K; Smidt I; Mikelsaar RH; Mikelsaar M; Verrips T; Hammarström L; Marcotte H
    Infect Immun; 2016 Feb; 84(2):395-406. PubMed ID: 26573738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of a naïve library of camelid single domain antibodies.
    Olichon A; de Marco A
    Methods Mol Biol; 2012; 911():65-78. PubMed ID: 22886246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiautomated panning of naive camelidae libraries and selection of single-domain antibodies against peptide antigens.
    Kumaran J; Mackenzie CR; Arbabi-Ghahroudi M
    Methods Mol Biol; 2012; 911():105-24. PubMed ID: 22886248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease.
    Kandalaft H; Hussack G; Aubry A; van Faassen H; Guan Y; Arbabi-Ghahroudi M; MacKenzie R; Logan SM; Tanha J
    Appl Microbiol Biotechnol; 2015 Oct; 99(20):8549-62. PubMed ID: 25936376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of chymosin secretion by simultaneous expression with chymosin-binding llama single-domain antibody fragments in yeast.
    Harmsen MM; Smits CB; de Geus B
    Appl Microbiol Biotechnol; 2002 Dec; 60(4):449-54. PubMed ID: 12466886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
    Deng XK; Nesbit LA; Morrow KJ
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.
    Hussack G; Arbabi-Ghahroudi M; van Faassen H; Songer JG; Ng KK; MacKenzie R; Tanha J
    J Biol Chem; 2011 Mar; 286(11):8961-76. PubMed ID: 21216961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins.
    Harmsen MM; Van Solt CB; Fijten HP; Van Setten MC
    Vaccine; 2005 Sep; 23(41):4926-34. PubMed ID: 15992972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of single-domain antibodies with an engineered disulfide bond.
    Hussack G; Mackenzie CR; Tanha J
    Methods Mol Biol; 2012; 911():417-29. PubMed ID: 22886266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Llama single domain antibodies as a tool for molecular mimicry.
    Zarebski LM; Urrutia M; Goldbaum FA
    J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of Camelid Single-Domain Antibodies Against Native Proteins Using Recombinant Multivalent Peptide Ligands.
    Alturki NA; Henry KA; MacKenzie CR; Arbabi-Ghahroudi M
    Methods Mol Biol; 2015; 1348():167-89. PubMed ID: 26424272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity anti-Internalin B VHH antibody fragments isolated from naturally and artificially immunized repertoires.
    Gene RW; Kumaran J; Aroche C; van Faassen H; Hall JC; MacKenzie CR; Arbabi-Ghahroudi M
    J Immunol Methods; 2015 Jan; 416():29-39. PubMed ID: 25450000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lateral recognition of a dye hapten by a llama VHH domain.
    Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C
    J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.
    Alvarez-Rueda N; Behar G; Ferré V; Pugnière M; Roquet F; Gastinel L; Jacquot C; Aubry J; Baty D; Barbet J; Birklé S
    Mol Immunol; 2007 Mar; 44(7):1680-90. PubMed ID: 17011035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity maturation of single-domain antibodies by yeast surface display.
    Koide A; Koide S
    Methods Mol Biol; 2012; 911():431-43. PubMed ID: 22886267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
    Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
    Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
    Kyne L; Warny M; Qamar A; Kelly CP
    N Engl J Med; 2000 Feb; 342(6):390-7. PubMed ID: 10666429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.